Literature DB >> 29508261

Pathology and images of radiation-induced hepatitis: a review article.

Shigeyuki Takamatsu1, Kazuto Kozaka2, Satoshi Kobayashi2, Norihide Yoneda2, Kotaro Yoshida2, Dai Inoue2, Azusa Kitao2, Takahiro Ogi2, Tetsuya Minami2, Wataru Kouda2, Tomoyasu Kumano3, Nobukazu Fuwa4, Osamu Matsui2, Toshifumi Gabata2.   

Abstract

Recent advances in highly conformal radiotherapies greatly extend the indications for radiotherapy of liver tumors. However, because of poor tolerance to hepatic radiation, estimation of the intensity of irradiation of the liver is important, particularly for a cirrhotic liver. Knowledge of radiation-induced hepatitis is important for understanding how to optimize hepatic radiation therapy. Pathological changes of the irradiated liver, which include perivenular fibrosis, sinusoidal obstruction, and damage to Kupffer cells and hepatocytes, can be visualized using clinical imaging techniques. This review article discusses and illustrates the pathological and radiological changes of hepatic tumors and the surrounding parenchyma of the irradiated liver.

Entities:  

Keywords:  Focal liver injury; Focal liver reaction; Hepatocellular carcinoma; Pathology; Radiation-induced liver disease; Threshold dose

Mesh:

Year:  2018        PMID: 29508261     DOI: 10.1007/s11604-018-0728-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  57 in total

1.  Recurrent hepatocellular carcinoma versus radiation-induced hepatic injury: differential diagnosis with MR imaging.

Authors:  H Onaya; Y Itai; T Ahmadi; H Yoshioka; T Okumura; Y Akine; H Tsuji; H Tsujii
Journal:  Magn Reson Imaging       Date:  2001-01       Impact factor: 2.546

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 3.  Partial volume tolerance of the liver to radiation.

Authors:  Laura A Dawson; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2005-10       Impact factor: 5.934

4.  Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.

Authors:  Naoko Sanuki; Atsuya Takeda; Yohei Oku; Takahisa Eriguchi; Shuichi Nishimura; Yosuke Aoki; Tomikazu Mizuno; Shogo Iwabuchi; Etsuo Kunieda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

5.  Preservation of hypervascularity in hepatocellular carcinoma after effective proton-beam radiotherapy--CT observation.

Authors:  T Ahmadi; T Okumura; H Onaya; Y Akine; Y Itai
Journal:  Clin Radiol       Date:  1999-04       Impact factor: 2.350

6.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

7.  Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.

Authors:  Ricarda Rühl; Lutz Lüdemann; Anna Czarnecka; Florian Streitparth; Max Seidensticker; Konrad Mohnike; Maciej Pech; Peter Wust; Jens Ricke
Journal:  Radiat Oncol       Date:  2010-05-27       Impact factor: 3.481

8.  Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.

Authors:  Zhi-Yong Xu; Shi-Xiong Liang; Ji Zhu; Xiao-Dong Zhu; Jian-Dong Zhao; Hai-Jie Lu; Yun-Li Yang; Long Chen; An-Yu Wang; Xiao-Long Fu; Guo-Liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-20       Impact factor: 7.038

9.  Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

Authors:  Alejandro Forner; Carmen Ayuso; María Varela; Jordi Rimola; Amelia J Hessheimer; Carlos Rodriguez de Lope; María Reig; Luís Bianchi; Josep M Llovet; Jordi Bruix
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

10.  Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.

Authors:  Shigeyuki Takamatsu; Kazutaka Yamamoto; Yoshikazu Maeda; Mariko Kawamura; Satoshi Shibata; Yoshitaka Sato; Kazuki Terashima; Yasuhiro Shimizu; Yuji Tameshige; Makoto Sasaki; Satoko Asahi; Tamaki Kondou; Satoshi Kobayashi; Osamu Matsui; Toshifumi Gabata
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

View more
  9 in total

Review 1.  SBRT for HCC: Overview of technique and treatment response assessment.

Authors:  Kimberly L Shampain; Caitlin E Hackett; Sohrab Towfighi; Anum Aslam; William R Masch; Alison C Harris; Silvia D Chang; Kanika Khanna; Vivek Mendiratta; Ahmed M Gabr; Dawn Owen; Mishal Mendiratta-Lala
Journal:  Abdom Radiol (NY)       Date:  2021-05-07

2.  Pathological Appearance of Focal Liver Reactions after Radiotherapy for Hepatocellular Carcinoma.

Authors:  Masahiro Okada; Kazushi Numata; Hiromi Nihonmatsu; Kengo Tomita; Atsuya Takeda; Kenichiro Tago; Tomoko Hyodo; Takahisa Eriguchi; Masayuki Nakano
Journal:  Diagnostics (Basel)       Date:  2022-04-25

3.  Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.

Authors:  Qiuyan Lin; Xiaoquan Huang; Canmei Zhong; Tiancheng Luo; Xiaoqing Zeng; Shiyao Chen
Journal:  Cancer Med       Date:  2019-01-18       Impact factor: 4.452

4.  Evaluation of Threshold Dose of Damaged Hepatic Tissue After Carbon-Ion Radiation Therapy Using Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging.

Authors:  Masashi Ebara; Kei Shibuya; Hirofumi Shimada; Motohiro Kawashima; Hiromi Hirasawa; Ayako Taketomi-Takahashi; Tatsuya Ohno; Yoshito Tsushima
Journal:  Adv Radiat Oncol       Date:  2021-08-14

5.  Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?

Authors:  Guanyu Chen; Dechao Jiao; Sheng Peng; Xi Chen; Yanling Zhang; Letao Lin; Zhihui Zhong; Yong Li; Kaihao Xu; Fujun Zhang
Journal:  Eur Radiol       Date:  2022-08-18       Impact factor: 7.034

6.  Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.

Authors:  Hiroaki Takahashi; Yuta Sekino; Kensaku Mori; Toshiyuki Okumura; Katsuhiro Nasu; Kuniaki Fukuda; Sota Masuoka; Takashi Iizumi; Naoyuki Hasegawa; Hideyuki Sakurai; Manabu Minami
Journal:  Br J Radiol       Date:  2019-11-07       Impact factor: 3.039

7.  Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma.

Authors:  Akihiro Funaoka; Kazushi Numata; Atsuya Takeda; Yusuke Saigusa; Yuichirou Tsurugai; Hiromi Nihonmatsu; Makoto Chuma; Hiroyuki Fukuda; Masahiro Okada; Masayuki Nakano; Shin Maeda
Journal:  Diagnostics (Basel)       Date:  2021-03-09

8.  Evolving development of multi-parametric normal tissue complication probability model for liver radiotherapy.

Authors:  Chiao-Ling Tsai; Jason Chia-Hsien Cheng
Journal:  Transl Cancer Res       Date:  2019-03       Impact factor: 1.241

9.  Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy.

Authors:  Po-Chien Shen; Wen-Yen Huang; Yang-Hong Dai; Cheng-Hsiang Lo; Jen-Fu Yang; Yu-Fu Su; Ying-Fu Wang; Chia-Feng Lu; Chun-Shu Lin
Journal:  Biomedicines       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.